HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CIR Moves To Reopen Retinol Assessment To Examine New Data

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel will consider new data as it reexamines the safety of retinol and retinyl palmitate in cosmetics. Panel opts not to reopen review of triclosan or parabens.

You may also be interested in...

CIR Proposes Prioritizing Triclosan For Review In 2018

The Cosmetic Ingredient Review Expert Panel’s draft ingredient priority list for 2018 review consists of 14 ingredients, including triclosan. At their April meeting, panelists cited the potential for consumer confusion following recent FDA action banning the ingredient’s OTC use in antibacterial soaps, as well as endocrine-disruption concerns voiced by NGOs.

CIR Panel Grapples With Interpreting NTP Retinyl Palmitate Study

The Cosmetic Ingredient Review Expert Panel examined the safety of retinol and related ingredients at its June 10-11 meeting, ultimately deciding not to make a safety determination until receiving further data from the National Toxicology Program.

Hair-Smoothing Council To Ask CIR To Reconsider Methylene Glycol

At its June 10-11 meeting, the Cosmetic Ingredient Review Expert Panel will hear a presentation from the Professional Keratin Smoothing Council and consider altering its initial “unsafe” assessment for methylene glycol used in heated hair-smoothing products.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts